You are here

What we do

Overview of TB in South Africa

South Africa is one of the 14 countries with the highest burdens of tuberculosis (TB), TB / HIV and multidrug-resistant TB (MDR TB), with the World Health Organization (WHO) reporting an estimate incidence of 454,000 cases of active TB in 2015. TB is the top natural cause of death in South Africa, accounting for about 8% of all deaths recorded in the country of the 294,603 TB cases recorded in 2015, 97% knew their HIV status , with 57%testing positive for HIV.

Encouragingly, South Africa has assumed a position of leadership in the global  fight against TB, including scaling up interventions aimed at achieving the 90-90-90 targets for TB as outlined in the Global Plan to End TB. The Government of improving treatment success rates for new pulmonary smear positive TB patients (79%), reducing lost-to-follow up rates (6.1%) and expanding access to improved TB diagnosis . More than 400,000 TB cases have been diagnosed since 2011 by GeneXpert MTB/RIF rapid testing.

In its National Strategic Plan (NSP) for HIV, TB and Sexually Transmitted Infections 2017 - 2022, South Africa has set out eight major goals and many objectives and interventions that together will support the achievement of zero new TB infections and zero preventable deaths associated with TB. This vision is mirrored in the Post-2015 End TB Strategy of the World Health Organization (WHO), which sets similar ambitious targets for eliminating TB by 2035.

Patients wait at a hospital implementing FAST to be screened and tested for TB
Patients wait at a hospital implementing FAST to be screened and tested for TB

Patients wait at a hospital implementing FAST to be screened and tested for TB
Hospital CEOs sign a pledge to improve Infection Prevention and Control in their health facilities

 

What we do?

Through our strategies and programmes, which are aligned to the South Africa National Strategic Plan for HIV/AIDS, Sexually Transmitted Infections and TB (2017-2022),  we aim to reduce TB infections, increase the sustainability of effective TB response systems and improve the care and treatment of vulnerable populations, such as women and youth. The project also aims to improve the prevention, diagnosis, management and care of persons with TB, TB/HIV and multi drug-resistant TB (MDR-TB).

What do we aim to achieve?

Through effective collaboration and partnership with the Government of South Africa, the National Department of Health and provincial departments of health in all nine provinces, as well as with various public and private stakeholders, the USAID Tuberculosis South Africa Project aims to contribute to South Africa achieving the following targets by 2020:

  • 90% treatment success rate among persons with drug-sensitive TB (DS-TB)
  • 75% treatment success for those with MDR-TB
  • 100% initiation of persons with confirmed MDR-TB on appropriate treatment
  • 90% antiretroviral therapy (ART) coverage for patients with dual TB/HIV disease.